FDA label
What is Gavilyte-n used for?
Gavilyte-n contains polyethylene glycol 3350, sodium chloride, sodium bicarbonate and potassium chloride. The FDA-approved uses below are quoted from the Indications and Usage section of its DailyMed label.
Source: DailyMed SPL label file dated 2026-10-23. Publisher page
The FDA label says: “GaviLyte-N is indicated for bowel cleansing prior to colonoscopy in adults and pediatric patients aged 6 months or greater.”
Run it in Rivvi
Which 2027 plans near you dropped or restricted Gavilyte-n?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Gavilyte-n, powder, for solution
Indications and Usage, quoted from the label by Lupin Pharmaceuticals,Inc. (ANDA090019). Cross-references to other label sections are left out.
GaviLyte-N is indicated for bowel cleansing prior to colonoscopy in adults and pediatric patients aged 6 months or greater.
Source: DailyMed label, set id 27195187-75a3-431f-90d9-84da1b94e849, version 7, effective September 10, 2025. NDC 43386-050, one of 1 listing for this product.
Questions
What is Gavilyte-n used for?
The FDA label says: “GaviLyte-N is indicated for bowel cleansing prior to colonoscopy in adults and pediatric patients aged 6 months or greater.”
What drug class is Gavilyte-n?
FDA lists polyethylene glycol 3350, sodium chloride, sodium bicarbonate and potassium chloride in the Osmotic Laxative and Potassium Salt established pharmacologic class.
Does this page cover off-label uses or dosing?
No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.